ConductScience.org, home

Trial · NCT01216410

Prevention of Intraoperative Nausea and Vomiting During Cesarean Section

NCT01216410, Not applicable, Completed, Duke University; results first posted 2013-03-25

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Prevention of Intraoperative Nausea and Vomiting During Cesarean Section. Trials, record NCT01216410. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01216410

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Prevention of Intraoperative Nausea and Vomiting During Cesarean Section
NCT number
NCT01216410
Status
Completed
Phases
Not applicable
Enrollment
306 participants, actual
Lead sponsor
Duke University
Conditions
Cesarean Delivery
Interventions
Metoclopramide, Phenylephrine infusion, Combination Group
First posted
2010-10-07
Last updated
2014-08-06
Results first posted
2013-03-25

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIntraoperative Nausea and VomitingIntraoperativelyComparison of intraoperative nausea and vomiting between the 3 groups.
SecondaryPostoperative Nausea and Vomiting (PONV)0-2h, 2-6h, 6-24h
SecondaryPruritus0-24 hrs
SecondarySatisfaction24 h1=very satisfied, 2=somewhat satisfied, 3= neither satisfied nor dissatisfied, 4=somewhat dissatisfied, 5= very dissatisfied. Number of very satisfied subjects posted.
SecondaryMaternal HemodynamicsIntraoperativelyThe number of patients with systolic blood pressure decrease to less than 20 % of baseline intraoperatively

Outcomes5

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYIntraoperative Nausea and VomitingIntraoperativelyparticipantsNUMBER
SECONDARYPostoperative Nausea and Vomiting (PONV)0-2h, 2-6h, 6-24hparticipantsNUMBER
SECONDARYPruritus0-24 hrsparticipantsNUMBER
SECONDARYSatisfaction24 hparticipantsNUMBER
SECONDARYMaternal HemodynamicsIntraoperativelyparticipants with SBP< 20 % baselineNUMBER

Results by group21

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Intraoperative Nausea and VomitingCombination Group23participants
Intraoperative Nausea and VomitingMetoclopramide31participants
Intraoperative Nausea and VomitingPhenylephrine Infusion49participants
Postoperative Nausea and Vomiting (PONV)Combination Group0-2 hrs PONV20participants
Postoperative Nausea and Vomiting (PONV)Metoclopramide0-2 hrs PONV33participants
Postoperative Nausea and Vomiting (PONV)Phenylephrine Infusion0-2 hrs PONV39participants
Postoperative Nausea and Vomiting (PONV)Combination Group2-6 hrs PONV28participants
Postoperative Nausea and Vomiting (PONV)Metoclopramide2-6 hrs PONV35participants
Postoperative Nausea and Vomiting (PONV)Phenylephrine Infusion2-6 hrs PONV41participants
Postoperative Nausea and Vomiting (PONV)Combination Group6-24 hrs PONV22participants

Participant flow9

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDCombination Group103
Overall StudySTARTEDMetoclopramide100
Overall StudySTARTEDPhenylephrine Infusion103
Overall StudyCOMPLETEDCombination Group101
Overall StudyCOMPLETEDMetoclopramide99
Overall StudyCOMPLETEDPhenylephrine Infusion100
Overall StudyNOT COMPLETEDCombination Group2
Overall StudyNOT COMPLETEDMetoclopramide1
Overall StudyNOT COMPLETEDPhenylephrine Infusion3

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals9

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityCombination Group
Total, all-cause mortalityMetoclopramide
Total, all-cause mortalityPhenylephrine Infusion
Total, other adverse eventsCombination Group0101
Total, other adverse eventsMetoclopramide099
Total, other adverse eventsPhenylephrine Infusion0100
Total, serious adverse eventsCombination Group0101
Total, serious adverse eventsMetoclopramide099
Total, serious adverse eventsPhenylephrine Infusion0100

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
23635626DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01216410

GET https://conductscience.org/api/trials/v1/NCT01216410/results?page=2